Modification in body weight associated with antiepileptic drugs
Antiepileptic drugs (AED) may cause body weight changes. OBJECTIVE: To evaluate the dietary habits and body weight associated with AED in epileptic patients. METHOD: Sixty-six patients were subjected to two interviews, and had their weight and body mass index calculated and compared at both times, interval between six to eight months. RESULTS: It was observed that 59.1% showed weight gain. The patients who had no weight gain had a greater proportion of individuals who engaged in some form of physical activity. However, of the 45 patients who maintained their initial dietary and medication pattern, 75.6% recorded a weight gain. Weight gain was seen in 66.7% of patients on carbamazepine (n=18), 60% on valproate (n=5), 50% on carbamazepine+clobazam treatment (n=14), and 58.3% of patients on other(s) polytherapy (n=12). CONCLUSION: The patient should be alerted to possible weight gain, and should be advised about dieting and participating in regular physical activity.
Main Authors: | , |
---|---|
Format: | Digital revista |
Language: | English |
Published: |
Academia Brasileira de Neurologia - ABNEURO
2010
|
Online Access: | http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0004-282X2010000200024 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
id |
oai:scielo:S0004-282X2010000200024 |
---|---|
record_format |
ojs |
spelling |
oai:scielo:S0004-282X20100002000242010-04-28Modification in body weight associated with antiepileptic drugsGaspari,Camilla N. DeGuerreiro,Carlos A.M. epilepsy antiepileptic drugs dietary habits body weight Antiepileptic drugs (AED) may cause body weight changes. OBJECTIVE: To evaluate the dietary habits and body weight associated with AED in epileptic patients. METHOD: Sixty-six patients were subjected to two interviews, and had their weight and body mass index calculated and compared at both times, interval between six to eight months. RESULTS: It was observed that 59.1% showed weight gain. The patients who had no weight gain had a greater proportion of individuals who engaged in some form of physical activity. However, of the 45 patients who maintained their initial dietary and medication pattern, 75.6% recorded a weight gain. Weight gain was seen in 66.7% of patients on carbamazepine (n=18), 60% on valproate (n=5), 50% on carbamazepine+clobazam treatment (n=14), and 58.3% of patients on other(s) polytherapy (n=12). CONCLUSION: The patient should be alerted to possible weight gain, and should be advised about dieting and participating in regular physical activity.info:eu-repo/semantics/openAccessAcademia Brasileira de Neurologia - ABNEUROArquivos de Neuro-Psiquiatria v.68 n.2 20102010-04-01info:eu-repo/semantics/articletext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S0004-282X2010000200024en10.1590/S0004-282X2010000200024 |
institution |
SCIELO |
collection |
OJS |
country |
Brasil |
countrycode |
BR |
component |
Revista |
access |
En linea |
databasecode |
rev-scielo-br |
tag |
revista |
region |
America del Sur |
libraryname |
SciELO |
language |
English |
format |
Digital |
author |
Gaspari,Camilla N. De Guerreiro,Carlos A.M. |
spellingShingle |
Gaspari,Camilla N. De Guerreiro,Carlos A.M. Modification in body weight associated with antiepileptic drugs |
author_facet |
Gaspari,Camilla N. De Guerreiro,Carlos A.M. |
author_sort |
Gaspari,Camilla N. De |
title |
Modification in body weight associated with antiepileptic drugs |
title_short |
Modification in body weight associated with antiepileptic drugs |
title_full |
Modification in body weight associated with antiepileptic drugs |
title_fullStr |
Modification in body weight associated with antiepileptic drugs |
title_full_unstemmed |
Modification in body weight associated with antiepileptic drugs |
title_sort |
modification in body weight associated with antiepileptic drugs |
description |
Antiepileptic drugs (AED) may cause body weight changes. OBJECTIVE: To evaluate the dietary habits and body weight associated with AED in epileptic patients. METHOD: Sixty-six patients were subjected to two interviews, and had their weight and body mass index calculated and compared at both times, interval between six to eight months. RESULTS: It was observed that 59.1% showed weight gain. The patients who had no weight gain had a greater proportion of individuals who engaged in some form of physical activity. However, of the 45 patients who maintained their initial dietary and medication pattern, 75.6% recorded a weight gain. Weight gain was seen in 66.7% of patients on carbamazepine (n=18), 60% on valproate (n=5), 50% on carbamazepine+clobazam treatment (n=14), and 58.3% of patients on other(s) polytherapy (n=12). CONCLUSION: The patient should be alerted to possible weight gain, and should be advised about dieting and participating in regular physical activity. |
publisher |
Academia Brasileira de Neurologia - ABNEURO |
publishDate |
2010 |
url |
http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0004-282X2010000200024 |
work_keys_str_mv |
AT gasparicamillande modificationinbodyweightassociatedwithantiepilepticdrugs AT guerreirocarlosam modificationinbodyweightassociatedwithantiepilepticdrugs |
_version_ |
1756374480187293696 |